Atlas Trials

Study to Assess Effectiveness of Oral Atogepant in Adult Participants For Prevention of Migraine in the United Kingdom

Clinical trial NCT07690215 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07690215
Sponsor
AbbVie
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Migraine
Start date
2026-09-01
Primary completion
2028-03-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.